##gff-version 3
##sequence-region P43699 1 371
P43699	UniProtKB	Chain	1	371	.	.	.	ID=PRO_0000049343;Note=Homeobox protein Nkx-2.1	
P43699	UniProtKB	DNA binding	161	220	.	.	.	Note=Homeobox;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00108	
P43699	UniProtKB	Compositional bias	234	243	.	.	.	Note=Poly-Gly	
P43699	UniProtKB	Compositional bias	246	253	.	.	.	Note=Poly-Gln	
P43699	UniProtKB	Compositional bias	294	303	.	.	.	Note=Poly-Ala	
P43699	UniProtKB	Modified residue	254	254	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P23441	
P43699	UniProtKB	Alternative sequence	1	1	.	.	.	ID=VSP_037890;Note=In isoform 3. M->MWSGGSGKARGWEAAAGGRSSPGRLSRRRIM;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:9545595,ECO:0000303|Ref.6;Dbxref=PMID:15489334,PMID:9545595	
P43699	UniProtKB	Natural variant	172	172	.	.	.	ID=VAR_075209;Note=In BHC%3B decrease in DNA-binding%3B no effect on transcription activation from thyroglobulin/TG%2C nor from pulmonary surfactant-associated protein C/SFTPC gene promoters. Q->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26723978;Dbxref=PMID:26723978	
P43699	UniProtKB	Natural variant	179	179	.	.	.	ID=VAR_077542;Note=In BHC%3B unknown pathological significance. R->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24453141;Dbxref=PMID:24453141	
P43699	UniProtKB	Natural variant	203	203	.	.	.	ID=VAR_073040;Note=In CAHTP. T->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24714694;Dbxref=PMID:24714694	
P43699	UniProtKB	Natural variant	205	205	.	.	.	ID=VAR_034906;Note=In CAHTP. V->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11854319,ECO:0000269|PubMed:24714694;Dbxref=dbSNP:rs137852692,PMID:11854319,PMID:24714694	
P43699	UniProtKB	Natural variant	208	208	.	.	.	ID=VAR_015188;Note=In BHC. W->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11971878;Dbxref=dbSNP:rs28936672,PMID:11971878	
P43699	UniProtKB	Natural variant	208	208	.	.	.	ID=VAR_075210;Note=In BHC%3B loss of transcription activation. W->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26723978;Dbxref=PMID:26723978	
P43699	UniProtKB	Natural variant	213	213	.	.	.	ID=VAR_015189;Note=In BHC. R->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11971878;Dbxref=dbSNP:rs28936671,PMID:11971878	
P43699	UniProtKB	Natural variant	339	339	.	.	.	ID=VAR_075769;Note=In NMTC1%3B loss of transcription regulatory region DNA binding%3B decreased transcription factor activity%2C sequence-specific DNA binding%3B tested for the thyroglobulin gene%3B associated with dominant impairment of thyroid-specific genes transcription and increased thyroid cells proliferation. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19176457;Dbxref=dbSNP:rs537209983,PMID:19176457	
P43699	UniProtKB	Sequence conflict	49	49	.	.	.	Note=P->H;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P43699	UniProtKB	Sequence conflict	49	49	.	.	.	Note=P->H;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P43699	UniProtKB	Sequence conflict	61	61	.	.	.	Note=H->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P43699	UniProtKB	Sequence conflict	61	61	.	.	.	Note=H->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P43699	UniProtKB	Sequence conflict	158	158	.	.	.	Note=S->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P43699	UniProtKB	Sequence conflict	158	158	.	.	.	Note=S->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P43699	UniProtKB	Sequence conflict	161	161	.	.	.	Note=R->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P43699	UniProtKB	Sequence conflict	161	161	.	.	.	Note=R->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
